175 related articles for article (PubMed ID: 17189268)
1. Interferon regulatory factor-8 is indispensable for the expression of promyelocytic leukemia and the formation of nuclear bodies in myeloid cells.
Dror N; Rave-Harel N; Burchert A; Azriel A; Tamura T; Tailor P; Neubauer A; Ozato K; Levi BZ
J Biol Chem; 2007 Feb; 282(8):5633-40. PubMed ID: 17189268
[TBL] [Abstract][Full Text] [Related]
2. PML is a key component for the differentiation of myeloid progenitor cells to macrophages.
Khalfin-Rabinovich Y; Weinstein A; Levi BZ
Int Immunol; 2011 Apr; 23(4):287-96. PubMed ID: 21427174
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemia.
Waight JD; Banik D; Griffiths EA; Nemeth MJ; Abrams SI
J Biol Chem; 2014 May; 289(22):15642-52. PubMed ID: 24753251
[TBL] [Abstract][Full Text] [Related]
4. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias.
Schmidt M; Nagel S; Proba J; Thiede C; Ritter M; Waring JF; Rosenbauer F; Huhn D; Wittig B; Horak I; Neubauer A
Blood; 1998 Jan; 91(1):22-9. PubMed ID: 9414265
[TBL] [Abstract][Full Text] [Related]
5. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
6. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
7. The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15(Ink4b) in murine myeloid cells.
Schmidt M; Bies J; Tamura T; Ozato K; Wolff L
Blood; 2004 Jun; 103(11):4142-9. PubMed ID: 14976051
[TBL] [Abstract][Full Text] [Related]
8. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element.
Meraro D; Gleit-Kielmanowicz M; Hauser H; Levi BZ
J Immunol; 2002 Jun; 168(12):6224-31. PubMed ID: 12055236
[TBL] [Abstract][Full Text] [Related]
9. PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.
Yoshida H; Ichikawa H; Tagata Y; Katsumoto T; Ohnishi K; Akao Y; Naoe T; Pandolfi PP; Kitabayashi I
Mol Cell Biol; 2007 Aug; 27(16):5819-34. PubMed ID: 17562868
[TBL] [Abstract][Full Text] [Related]
10. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene.
Marecki S; Riendeau CJ; Liang MD; Fenton MJ
J Immunol; 2001 Jun; 166(11):6829-38. PubMed ID: 11359842
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional link of the leukemia-associated factors AML1 and PML.
Nguyen LA; Pandolfi PP; Aikawa Y; Tagata Y; Ohki M; Kitabayashi I
Blood; 2005 Jan; 105(1):292-300. PubMed ID: 15331439
[TBL] [Abstract][Full Text] [Related]
12. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
Condemine W; Takahashi Y; Le Bras M; de Thé H
J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
[TBL] [Abstract][Full Text] [Related]
13. PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells.
Huang W; Horvath E; Eklund EA
J Biol Chem; 2007 Mar; 282(9):6629-43. PubMed ID: 17200120
[TBL] [Abstract][Full Text] [Related]
14. ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells.
Tamura T; Kong HJ; Tunyaplin C; Tsujimura H; Calame K; Ozato K
Blood; 2003 Dec; 102(13):4547-54. PubMed ID: 12933588
[TBL] [Abstract][Full Text] [Related]
15. Characterization of endogenous human promyelocytic leukemia isoforms.
Condemine W; Takahashi Y; Zhu J; Puvion-Dutilleul F; Guegan S; Janin A; de Thé H
Cancer Res; 2006 Jun; 66(12):6192-8. PubMed ID: 16778193
[TBL] [Abstract][Full Text] [Related]
16. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.
Tamura T; Ozato K
J Interferon Cytokine Res; 2002 Jan; 22(1):145-52. PubMed ID: 11846985
[TBL] [Abstract][Full Text] [Related]
17. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
[TBL] [Abstract][Full Text] [Related]
18. PML positively regulates interferon gamma signaling.
El Bougrini J; Dianoux L; Chelbi-Alix MK
Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
[TBL] [Abstract][Full Text] [Related]
19. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
Reineke EL; Kao HY
Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
[TBL] [Abstract][Full Text] [Related]
20. Identification of IRF-8 and IRF-1 target genes in activated macrophages.
Dror N; Alter-Koltunoff M; Azriel A; Amariglio N; Jacob-Hirsch J; Zeligson S; Morgenstern A; Tamura T; Hauser H; Rechavi G; Ozato K; Levi BZ
Mol Immunol; 2007 Jan; 44(4):338-46. PubMed ID: 16597464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
